Daxor Corp
NASDAQ:DXR

Watchlist Manager
Daxor Corp Logo
Daxor Corp
NASDAQ:DXR
Watchlist
Price: 12.665 USD 2.88% Market Closed
Market Cap: 63.1m USD
Section:
 

Relative Value

The Relative Value of one DXR stock under the Base Case scenario is 0.065 USD. Compared to the current market price of 12.665 USD, Daxor Corp is Overvalued by 99%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DXR Relative Value
Base Case
0.065 USD
Overvaluation 99%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

952.2
P/S
P/S
Price to Sales
952.2
vs History
4
vs Industry
0
Median 3Y
265.2
Median 5Y
209.3
Industry
2.3
More Details
35.1
P/E
P/E
Price to Earnings
35.1
vs History
33
vs Industry
5
Median 3Y
26.2
Median 5Y
12.4
Industry
22.4
More Details
45.5
P/OCF
P/OCF
Price to OCF
45.5
vs History
14
vs Industry
0
Median 3Y
-12.6
Median 5Y
-16
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-67.8
Median 5Y
-21.5
Industry
21.5
More Details
1.8
P/B
P/B
Price to Book Value
1.8
vs History
46
vs Industry
60
Median 3Y
1.3
Median 5Y
1.6
Industry
2.2
More Details
956.1
EV/S
EV/S
Enterprise Value to Sales
956.1
vs History
4
vs Industry
1
Median 3Y
275.9
Median 5Y
210.9
Industry
2.5
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
-48.3
Median 5Y
-67.4
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-43.7
Median 5Y
-53
Industry
12
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-43.7
Median 5Y
-53
Industry
17.1
More Details
45.7
EV/OCF
EV/OCF
Enterprise Value to OCF
45.7
vs History
14
vs Industry
0
Median 3Y
-12.8
Median 5Y
-16.7
Industry
14.7
More Details
45.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
45.7
vs History
14
vs Industry
0
Median 3Y
-12.8
Median 5Y
-16.7
Industry
18.8
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
46
vs Industry
54
Median 3Y
1.3
Median 5Y
1.6
Industry
1.8
More Details

Multiples Across Competitors

DXR Competitors Multiples
Daxor Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Daxor Corp
NASDAQ:DXR
63.1m USD 952.2 35.1 -42.3 -42.3
US
Abbott Laboratories
NYSE:ABT
220.3B USD 5 15.8 20.1 28
US
Intuitive Surgical Inc
NASDAQ:ISRG
199.6B USD 20.8 72.7 55.7 67.9
US
Boston Scientific Corp
NYSE:BSX
140B USD 7.2 50.2 29.4 39.9
US
Stryker Corp
NYSE:SYK
134.8B USD 5.5 45.8 22.4 27.1
IE
Medtronic PLC
NYSE:MDT
126B USD 3.6 26.5 14.9 21.5
DE
Siemens Healthineers AG
XETRA:SHL
50.1B EUR 2.1 23.4 13.2 18.6
US
Becton Dickinson and Co
NYSE:BDX
55.8B USD 2.6 33.2 12.3 21
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.6B USD 13.4 54.2 38.9 43.1
US
Edwards Lifesciences Corp
NYSE:EW
49.3B USD 8.4 36 25.7 28.2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.5B USD 1.9 16.9 12.6 15.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Daxor Corp
NASDAQ:DXR
Average EV/EBITDA: 24.5
Negative Multiple: -42.3 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
20.1
12%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.7
26%
2.1
US
Boston Scientific Corp
NYSE:BSX
29.4
22%
1.3
US
Stryker Corp
NYSE:SYK
22.4
13%
1.7
IE
Medtronic PLC
NYSE:MDT
14.9
8%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
13.2
11%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.3
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.9
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.7
13%
2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
12.6
10%
1.3

See Also

Summary
DXR intrinsic value, competitors valuation, and company profile.
DCF Valuation
DXR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DXR stock valuation using valuation multiples.
Wall Street Estimates
DXR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DXR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.